No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Azacitidine / administration & dosage
-
Azacitidine / analogs & derivatives*
-
Azacitidine / pharmacology
-
Basic Helix-Loop-Helix Transcription Factors / genetics
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Cell Survival / genetics
-
Decitabine
-
Drug Synergism
-
Gene Expression Regulation, Leukemic / drug effects
-
Humans
-
Jurkat Cells
-
Mice
-
Neoplasm Proteins / genetics
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Receptors, Interleukin-7 / genetics
-
Reverse Transcriptase Polymerase Chain Reaction
-
Xenograft Model Antitumor Assays*
Substances
-
Antineoplastic Agents
-
Basic Helix-Loop-Helix Transcription Factors
-
LYL1 protein, human
-
Neoplasm Proteins
-
Receptors, Interleukin-7
-
Decitabine
-
Azacitidine